Literature DB >> 6416699

Cooperative studies of systemic chemotherapy. A review of the work of the EORTC Urological Group and of the Yorkshire Urological Cancer Research Group (YUCRG).

P H Smith, J A Child, J H Mulder, A T Van Oosterom, J A Martinez-Pineiro, B Richards, G Stoter, O Dalesio, M De Pauw, R Sylvester.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6416699     DOI： 10.1007/BF00256713

Source DB:  PubMed          Journal:  Cancer Chemother Pharmacol        ISSN： 0344-5704            Impact factor:   3.333


× No keyword cloud information.
  35 in total

1.  Invasive bladder cancer--definitive irradiation and salvage cystectomy.

Authors:  M J Wizenberg
Journal:  Semin Oncol       Date:  1979-06       Impact factor: 4.929

2.  Combination chemotherapy with cyclophosphamide, doxorubicin, and bleomycin for metastatic transitional cell carcinoma of the urinary tract.

Authors:  J A Levi; R S Aroney; D N Dalley
Journal:  Cancer Treat Rep       Date:  1980 Aug-Sep

3.  Combination chemotherapy (CISCA) for advanced urinary tract carcinoma. A preliminary report.

Authors:  J J Sternberg; R B Bracken; P B Handel; D E Johnson
Journal:  JAMA       Date:  1977-11-21       Impact factor: 56.272

4.  Cyclophosphamide, adriamycin and cisplatin combination chemotherapy in advanced bladder carcinoma: an EORTC phase II study.

Authors:  J H Mulder; S D Fossa; M De Pauw; A T Van Oosterom
Journal:  Eur J Cancer Clin Oncol       Date:  1982-01

5.  Chemotherapy of bladder carcinoma with cyclophosphamide and adriamycin.

Authors:  C Merrin; R Cartagena; Z Wajsman; G Baumgartner; G P Murphy
Journal:  J Urol       Date:  1975-12       Impact factor: 7.450

6.  Doxorubicin chemotherapy in advanced transitional cell carcinoma.

Authors:  S H Weinstein; J D Schmidt
Journal:  Urology       Date:  1976-10       Impact factor: 2.649

7.  The management of deeply infiltrating (T3) bladder carcinoma: controlled trial of radical radiotherapy versus preoperative radiotherapy and radical cystectomy (first report).

Authors:  D M Wallace; H J Bloom
Journal:  Br J Urol       Date:  1976

8.  Adjuvant chemotherapy and cancer cure.

Authors:  J R Bertino
Journal:  Int J Radiat Oncol Biol Phys       Date:  1982-01       Impact factor: 7.038

9.  The management of advanced bladder carcinoma.

Authors:  K R Kedia; C Gibbons; L Persky
Journal:  J Urol       Date:  1981-05       Impact factor: 7.450

10.  Methotrexate: an active drug in bladder cancer.

Authors:  R B Natale; A Yagoda; R C Watson; W F Whitmore; M Blumenreich; D W Braun
Journal:  Cancer       Date:  1981-03-15       Impact factor: 6.860
View more
  2 in total

1.  The chemotherapy of advanced bladder cancer.

Authors:  D W Newling; G Stoter; R Sylvester; M de Pauw
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333

2.  Postoperative systemic adjuvant chemotherapy for bladder cancer.

Authors:  H Kiyohara; M Kuroda; S Saiki; T Miki; T Kinouchi; M Usami; T Kotake
Journal:  Cancer Chemother Pharmacol       Date:  1987       Impact factor: 3.333
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.